Clinical Trials
29 trialsStudying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
Alliance for Clinical Trials in Oncology
Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Peritoneal Mesothelioma or Atypical Mesothelial Proliferation or From Ovarian, Colorectal, or Appendiceal Histologies
National Institutes of Health Clinical Center (CC)
BREGO
Institut du Cancer de Montpellier - Val d'Aurelle
Evaluation of the Preliminary Efficacy and Safety of DR30206 in Combination With Standard Therapy in Patients With Gastrointestinal Cancer
Zhejiang Doer Biologics Co., Ltd.
2 Versus 6 Hour Oxaliplatin Infusions in Patients With Gastrointestinal Cancers
Emory University
A Safety and Efficacy Study of ZW25 (Zanidatamab) Plus Combination Chemotherapy in HER2-expressing Gastrointestinal Cancers, Including Gastroesophageal Adenocarcinoma, Biliary Tract Cancer, and Colorectal Cancer
Jazz Pharmaceuticals
A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer
Pfizer
OCTASUR
Ukrainian Society of Clinical Oncology
A Study of IMU-131(HER-Vaxx) and Chemotherapy Compared to Chemotherapy Only in Patients With HER2 Positive Advanced Gastric Cancer
Imugene Limited
CENDIFOX
University of Kansas Medical Center
EXPLORING
The First Affiliated Hospital with Nanjing Medical University
C-Met Inhibitor AMG 337, Oxaliplatin, Leucovorin Calcium, and Fluorouracil in Treating Patients With Advanced Stomach or Esophageal Cancer
Eastern Cooperative Oncology Group
ALTER-C-002
Zhejiang University
PIPOX
Institut Cancerologie de l'Ouest
SOLAR
Taiho Pharmaceutical Co., Ltd.
RusGCG-01
Blokhin's Russian Cancer Research Center
GABLE
Baylor College of Medicine
Modufolin (Arfolitixorin) in Combination With 5-Fluorouracil Alone or Together With Oxaliplatin or Irinotecan in Colorectal Cancer
Isofol Medical AB
PALAESTRA
Lund University Hospital
SIRINOX
Institut du Cancer de Montpellier - Val d'Aurelle
IXOGoo1
AHS Cancer Control Alberta
Alisertib and Combination Chemotherapy in Treating Patients With Gastrointestinal Tumors
National Cancer Institute (NCI)
FluoHeart
Helsinki University Central Hospital
Monosialotetrahexosylganglioside for Treatment of Oxaliplatin Induced Neurotoxicity in Gastrointestinal Cancer
Tianjin Medical University Cancer Institute and Hospital
S-1, Oxaliplatin, and Irinotecan for Advanced Gastrointestinal Cancer
Hallym University Medical Center
Capecitabine and Oxaliplatin in Adenocarcinoma of the Small Bowel and Ampulla of Vater
M.D. Anderson Cancer Center
Study of DPD for Predicting Efficacy and Safety to S-1 Plus Oxaliplatin in Gastrointestinal Cancer
Xijing Hospital
FOLFOX4
Sanofi
TIROX
National Cancer Center, Korea